Kupelian PA - Search Results

1

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.

Thames HD, Kuban DA, DeSilvio ML, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Thames HD, et al. Among authors: kupelian pa. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):975-81. doi: 10.1016/j.ijrobp.2006.02.043. Epub 2006 Jun 5. Int J Radiat Oncol Biol Phys. 2006. PMID: 16750319

2

Treatment of endometrial carcinoma with radiation therapy alone.

Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ. Kupelian PA, et al. Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):817-24. doi: 10.1016/0360-3016(93)90454-4. Int J Radiat Oncol Biol Phys. 1993. PMID: 8244810 Review.

3

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

Kupelian P, Katcher J, Levin H, Zippe C, Klein E. Kupelian P, et al. Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7. Urology. 1996. PMID: 8753737

4

Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone.

Kupelian PA, Komaki R, Allen P. Kupelian PA, et al. Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):607-13. doi: 10.1016/s0360-3016(96)00364-1. Int J Radiat Oncol Biol Phys. 1996. PMID: 8948345

5

External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.

Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E. Kupelian P, et al. Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87. Cancer J Sci Am. 1997. PMID: 9099457

6

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone.

Katcher J, Kupelian PA, Zippe C, Klein EA, Sohn JW. Katcher J, et al. Among authors: kupelian pa. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):871-6. doi: 10.1016/s0360-3016(96)00617-7. Int J Radiat Oncol Biol Phys. 1997. PMID: 9128964

7

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA. Kupelian PA, et al. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52. doi: 10.1016/s0360-3016(96)00590-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169811

8

Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?

Keyser D, Kupelian PA, Zippe CD, Levin HS, Klein EA. Keyser D, et al. Among authors: kupelian pa. Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):723-9. doi: 10.1016/s0360-3016(97)00123-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9240638

9

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Mohan DS, et al. Among authors: kupelian pa. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):981-7. doi: 10.1016/s0360-3016(98)00296-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9869219

10

A mobile shield to reduce scatter radiation to the contralateral breast during radiotherapy for breast cancer: preclinical results.

Sohn JW, Macklis R, Suh JH, Kupelian P. Sohn JW, et al. Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1037-41. doi: 10.1016/s0360-3016(98)00506-9. Int J Radiat Oncol Biol Phys. 1999. PMID: 10192352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters